Nora D. Volkow, Director of the NIDA
40 ára afmælisráðstefna SÁÁ: Addiction Is a Chronic Brain Disease – What We Know Today Nora D. Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) Abstract Addiction is a disorder that involves complex interactions between genes, development and the social environment. Studies employing neuroimaging technology paired …Read more »
Valgerður Rúnarsdóttir, Medical Director at SÁÁ
40 ára afmælisráðstefna SÁÁ: Opioid addiction in Iceland SÁÁ Valgerður Rúnarsdóttir, MD, Medical Director at SÁÁ Abstract In Iceland, the opioid addiction problem is because of prescription opioid almost solely. Heroin is not generally found on the black market but prescription tablets are. Prescription drugs are part of the addiction problem in general, like in other …Read more »
Kári Stefánsson, forstjóri Íslenskrar erfðagreiningar
Erindi Kára Stefánssonar, forstjóra Íslenskrar erfðagreiningar, á málþinginu Fíkn og pólitík.
Arndís Sue Ching Löve, PhD student MS Pharm
40 ára afmælisráðstefna SÁÁ: Estimation of community drug abuse in the Reykjavík metropolitan area by wastewater analysis Arndís Sue Ching Löve, PhD student MS Pharm Abstract Introduction: Drug abuse has been a matter of concern worldwide due to the risks these substances pose to human health, and their connection to crime. Sewage epidemiology is a methodology used …Read more »
Nora D. Volkow, Director of the NIDA
40 ára afmælisráðstefna SÁÁ Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the …Read more »
Nora D. Volkow, Director of NIDA
40 ára afmælisráðstefna SÁÁ: Cannabis and society – can science guide public policies? Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) Nora D. Volkow, M.D., became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. Dr. …Read more »
Kári Stefánsson, CEO Decode Genetics
Kári Stefánsson, M.D., Dr. Med. has served as President, Chief Executive Officer and a Director since he founded deCODE genetics in August 1996. Dr. Stefánsson was appointed the Chairman of the Board of Directors of deCODE genetics in December 1999. From 1993 until April 1997, Dr. Stefánsson was a professor of Neurology, Neuropathology and Neuroscience …Read more »
Gregory Bunt, MD, FISAM
40 ára afmælisráðstefna SÁÁ: Medicinal Marijuana, Policy and Physician Gregory Bunt, MD FISAM, President, International Society of Addiction Medicine Diplomate, American Board of Psychiatry and Neurology, Clinical Assistant Professor of Psychiatry, NYU School of Medicine, New York, NY Dr. Gregory Bunt graduated medical school in 1983 from NYU School of Medicine, and completed his residency in Psychiatry …Read more »
Þórólfur Guðnason, Chief Epidemiologist
Seminar: Viral infections and addiction, HIV and Hepatitis C Chair – Þórólfur Guðnason MD, PhD, Chief Epidemiologist, Centre for Health Security and Communicable Disease Control, Directorate of Health
